Cytokinetics Overview

  • Founded
  • 1997
Founded
  • Status
  • Public
  • Employees
  • 184
Employees
  • Stock Symbol
  • CYTK
Stock Symbol
  • Share Price
  • $23.77
  • (As of Tuesday Closing)

Cytokinetics General Information

Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 280 East Grand Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytokinetics Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$23.77 $23.38 $14.71 - $30.14 $1.71B 71.7M 931K -$2.01

Cytokinetics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 1,328,910 1,197,178 514,256 177,368
Revenue 58,551 55,828 26,868 31,501
EBITDA (102,232) (92,112) (97,574) (87,677)
Net Income (134,989) (127,290) (121,692) (106,289)
Total Assets 577,062 533,803 289,814 211,178
Total Debt 228,316 138,938 136,068 43,184
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cytokinetics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cytokinetics‘s full profile, request access.

Request a free trial

Cytokinetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Cytokinetics‘s full profile, request access.

Request a free trial

Cytokinetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by
Pharmaceuticals
South San Francisco, CA
184 As of 2020
00000
000000000 00000

00000000

amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqu
0000000000000
Pasadena, CA
000 As of 0000
00.000
000000 - 000 00.000

000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
000000000000000
San Diego, CA
0 As of 0000
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cytokinetics Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arrowhead Pharmaceuticals Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
000000 Venture Capital-Backed San Diego, CA 0 00.000 0000000000 0 00.000
000000000 00000000 Formerly VC-backed Boston, MA 00 00000 000000000 00000
00000000 000000000 Formerly VC-backed Allschwil, Switzerland 0000 00000 000000&0 00000
0000 00000000 Formerly VC-backed Stamford, CT 00 00000 000000&0 00000
You’re viewing 5 of 16 competitors. Get the full list »

Cytokinetics Executive Team (10)

Name Title Board Seat Contact Info
Robert Blum Chief Executive Officer & Board Member
Ching Jaw Chief Financial Officer, Finance & Senior Vice President
Robert Wong Chief Accounting Officer, Accounting & Vice President
David Cragg Chief Administrative Officer, Administration & Executive
Fady Malik Executive Vice President
You’re viewing 5 of 10 executive team members. Get the full list »

Cytokinetics Board Members (9)

Name Representing Role Since
Edward Kaye MD Self Board Member 000 0000
John Henderson MD Cytokinetics Board Member 000 0000
Muna Bhanji Self Board Member 000 0000
Nancy Wysenski Self Board Member 000 0000
Patrick Gage Ph.D Self Chairman of the Board 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Cytokinetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytokinetics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cytokinetics‘s full profile, request access.

Request a free trial